Standard InChI: InChI=1S/C21H29N3O/c1-16(2)24(17(3)4)15-13-21(20(22)25,18-10-6-5-7-11-18)19-12-8-9-14-23-19/h5-12,14,16-17H,13,15H2,1-4H3,(H2,22,25)/t21-/m1/s1
1.Burke TR, Nelson WL, Mangion M, Hite GJ, Mokler CM, Ruenitz PC.. (1980) Resolution, absolute configuration, and antiarrhythmic properties of the enantiomers of disopyramide, 4-(diisopropylamino)-2-(2-pyridyl)-2-phenylbutyramide., 23 (9):[PMID:7411548][10.1021/jm00183a015]
2.Moda TL, Montanari CA, Andricopulo AD.. (2007) Hologram QSAR model for the prediction of human oral bioavailability., 15 (24):[PMID:17870541][10.1016/j.bmc.2007.08.060]
3.PubChem BioAssay data set,
4.PubChem BioAssay data set,
5.PubChem BioAssay data set,
6.Garrido A, Lepailleur A, Mignani SM, Dallemagne P, Rochais C.. (2020) hERG toxicity assessment: Useful guidelines for drug design., 195 [PMID:32283295][10.1016/j.ejmech.2020.112290]